Table 2.
Gene | All (n = 56) | AT (n = 26) | RT (n = 30) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Before | After | p value | Before | After | p value | Before | After | p value | ||||
COL1A1 | 0.821 ± 0.025 | 0.858 ± 0.032 | – | 0.19 | 0.857 ± 0.043 | 0.898 ± 0.053 | – | 0.37 | 0.789 ± 0.029 | 0.823 ± 0.037 | – | 0.36 |
COL1A2 | 0.826 ± 0.023 | 0.865 ± 0.026 | ↑ | < 0.10 | 0.862 ± 0.034 | 0.928 ± 0.043 | ↑ | < 0.10 | 0.795 ± 0.030 | 0.811 ± 0.027 | – | 0.60 |
COL3A1 | 0.895 ± 0.031 | 0.969 ± 0.033 | ↑ | < 0.01 | 0.945 ± 0.047 | 1.040 ± 0.055 | ↑ | < 0.05 | 0.851 ± 0.040 | 0.908 ± 0.037 | ↑ | < 0.10 |
COL5A1 | 0.727 ± 0.018 | 0.764 ± 0.021 | ↑ | < 0.05 | 0.757 ± 0.028 | 0.807 ± 0.035 | ↑ | < 0.10 | 0.702 ± 0.024 | 0.727 ± 0.025 | – | 0.26 |
COL6A1 | 0.809 ± 0.018 | 0.908 ± 0.023 | ↑ | < 0.001 | 0.845 ± 0.025 | 0.947 ± 0.035 | ↑ | < 0.05 | 0.778 ± 0.024 | 0.873 ± 0.028 | ↑ | < 0.001 |
COL12A1 | 0.981 ± 0.028 | 1.062 ± 0.032 | ↑ | < 0.01 | 1.044 ± 0.047 | 1.159 ± 0.052 | ↑ | < 0.01 | 0.926 ± 0.030 | 0.978 ± 0.035 | – | 0.10 |
COL14A1 | 0.835 ± 0.023 | 0.931 ± 0.027 | ↑ | < 0.001 | 0.887 ± 0.040 | 0.984 ± 0.042 | ↑ | < 0.05 | 0.791 ± 0.024 | 0.885 ± 0.034 | ↑ | < 0.01 |
HAS1 | 0.092 ± 0.013 | 0.102 ± 0.017 | – | 0.52 | 0.090 ± 0.013 | 0.115 ± 0.032 | – | 0.34 | 0.095 ± 0.021 | 0.091 ± 0.016 | – | 0.98 |
HAS2 | 0.177 ± 0.020 | 0.239 ± 0.022 | ↑ | < 0.001 | 0.163 ± 0.018 | 0.247 ± 0.026 | ↑ | < 0.001 | 0.190 ± 0.034 | 0.233 ± 0.035 | ↑ | < 0.01 |
DCN | 0.911 ± 0.029 | 0.994 ± 0.032 | ↑ | < 0.001 | 0.973 ± 0.043 | 1.080 ± 0.049 | ↑ | < 0.01 | 0.857 ± 0.036 | 0.919 ± 0.036 | ↑ | < 0.10 |
BGN | 0.685 ± 0.016 | 0.736 ± 0.021 | ↑ | < 0.01 | 0.722 ± 0.026 | 0.750 ± 0.036 | – | 0.31 | 0.653 ± 0.019 | 0.723 ± 0.024 | ↑ | < 0.001 |
VCAN | 0.595 ± 0.017 | 0.644 ± 0.019 | ↑ | < 0.01 | 0.635 ± 0.028 | 0.691 ± 0.034 | ↑ | < 0.05 | 0.561 ± 0.019 | 0.604 ± 0.019 | ↑ | < 0.01 |
CHPF | 1.062 ± 0.030 | 1.162 ± 0.037 | ↑ | < 0.001 | 1.146 ± 0.048 | 1.252 ± 0.052 | ↑ | < 0.05 | 0.989 ± 0.035 | 1.084 ± 0.048 | ↑ | < 0.01 |
CHSY1 | 1.040 ± 0.042 | 1.110 ± 0.047 | ↑ | < 0.05 | 1.106 ± 0.068 | 1.186 ± 0.071 | – | 0.17 | 0.981 ± 0.049 | 1.044 ± 0.060 | ↑ | < 0.05 |
CHSY3 | 1.630 ± 0.075 | 1.653 ± 0.075 | – | 0.65 | 1.766 ± 0.121 | 1.743 ± 0.098 | – | 0.79 | 1.513 ± 0.091 | 1.576 ± 0.111 | – | 0.31 |
ELN | 0.716 ± 0.036 | 0.638 ± 0.037 | ↓ | < 0.05 | 0.755 ± 0.052 | 0.651 ± 0.058 | ↓ | < 0.05 | 0.682 ± 0.051 | 0.626 ± 0.047 | – | 0.24 |
Values show the means of the relative level of gene expression calculated by the ΔΔCt method (where Ct is the threshold cycle) normalized with glyceraldehyde 3-phosphate dehydrogenase as the housekeeping gene and the control sample ± standard errors (SEs). Statistical analyses for the intragroup difference were performed with two-sided paired t tests.
AT aerobic training, BGN biglycan, CHPF chondroitin polymerizing factor, CHSY1 chondroitin sulfate synthase 1, CHSY3 chondroitin sulfate synthase 3, COL1A1 collagen type I α 1 chain, COL1A2 collagen type I α 2 chain, COL3A1 collagen type III α 1 chain, COL5A1 collagen type V α 1 chain, COL6A1 collagen type VI α 1 chain, COL12A1 collagen type XII α 1 chain, COL14A1 collagen type XIV α 1 chain, DCN decorin, ELN elastin, HAS1 hyaluronan synthase 1, HAS2 hyaluronan synthase 2, RT resistance training, VCAN versican.